331 related articles for article (PubMed ID: 16473397)
1. Role of prophylactic hysterectomy in patients at high risk for hereditary cancers.
Villella JA; Parmar M; Donohue K; Fahey C; Piver MS; Rodabaugh K
Gynecol Oncol; 2006 Sep; 102(3):475-9. PubMed ID: 16473397
[TBL] [Abstract][Full Text] [Related]
2. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
3. Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome.
Schmeler KM; Lynch HT; Chen LM; Munsell MF; Soliman PT; Clark MB; Daniels MS; White KG; Boyd-Rogers SG; Conrad PG; Yang KY; Rubin MM; Sun CC; Slomovitz BM; Gershenson DM; Lu KH
N Engl J Med; 2006 Jan; 354(3):261-9. PubMed ID: 16421367
[TBL] [Abstract][Full Text] [Related]
4. Predictors of occult neoplasia in women undergoing risk-reducing salpingo-oophorectomy.
Lamb JD; Garcia RL; Goff BA; Paley PJ; Swisher EM
Am J Obstet Gynecol; 2006 Jun; 194(6):1702-9. PubMed ID: 16731090
[TBL] [Abstract][Full Text] [Related]
5. Single-port risk-reducing salpingo-oophorectomy with and without hysterectomy: surgical outcomes and learning curve analysis.
Escobar PF; Starks DC; Fader AN; Barber M; Rojas-Espalliat L
Gynecol Oncol; 2010 Oct; 119(1):43-7. PubMed ID: 20579712
[TBL] [Abstract][Full Text] [Related]
6. Prophylactic bilateral salpingo-oophorectomy compared with surveillance in women with BRCA mutations.
Schmeler KM; Sun CC; Bodurka DC; White KG; Soliman PT; Uyei AR; Erlichman JL; Arun BK; Daniels MS; Rimes SA; Peterson SK; Slomovitz BM; Milam MR; Gershenson DM; Lu KH
Obstet Gynecol; 2006 Sep; 108(3 Pt 1):515-20. PubMed ID: 16946209
[TBL] [Abstract][Full Text] [Related]
7. Ovarian cancer in women with prior hysterectomy.
Davis R; Unger JB
J La State Med Soc; 2003; 155(2):113-5. PubMed ID: 12778998
[TBL] [Abstract][Full Text] [Related]
8. The significance of cytological mesothelial atypia diagnosed from peritoneal washings performed during risk-reducing salpingo-oophorectomy.
Eitan R; Soslow R; Lin O; Kauff ND; Liu L; Barakat RR; Chi DS
Gynecol Oncol; 2006 Aug; 102(2):315-8. PubMed ID: 16430946
[TBL] [Abstract][Full Text] [Related]
9. Hysterectomy, oophorectomy, and subsequent ovarian cancer risk.
Parazzini F; Negri E; La Vecchia C; Luchini L; Mezzopane R
Obstet Gynecol; 1993 Mar; 81(3):363-6. PubMed ID: 8437787
[TBL] [Abstract][Full Text] [Related]
10. The role of prophylactic oophorectomy in cancer prevention.
Averette HE; Nguyen HN
Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S38-41. PubMed ID: 7835808
[TBL] [Abstract][Full Text] [Related]
11. Attitudes toward prophylactic oophorectomy and screening utilization in women at increased risk of developing hereditary breast/ovarian cancer.
Meiser B; Butow P; Barratt A; Friedlander M; Gattas M; Kirk J; Suthers G; Walpole I; Tucker K
Gynecol Oncol; 1999 Oct; 75(1):122-9. PubMed ID: 10502438
[TBL] [Abstract][Full Text] [Related]
12. Prevention of ovarian cancer: a survey of the practice of prophylactic oophorectomy by consultant gynaecologists in Ireland.
Geary M; Geoghegan A; Foley M
Ir Med J; 1997; 90(5):186-7. PubMed ID: 9345830
[TBL] [Abstract][Full Text] [Related]
13. Gynecologic cancer prevention in Lynch syndrome/hereditary nonpolyposis colorectal cancer families.
Chen LM; Yang KY; Little SE; Cheung MK; Caughey AB
Obstet Gynecol; 2007 Jul; 110(1):18-25. PubMed ID: 17601891
[TBL] [Abstract][Full Text] [Related]
14. Hysterectomy with or without unilateral oophorectomy and risk of ovarian cancer.
Chiaffarino F; Parazzini F; Decarli A; Franceschi S; Talamini R; Montella M; La Vecchia C
Gynecol Oncol; 2005 May; 97(2):318-22. PubMed ID: 15863124
[TBL] [Abstract][Full Text] [Related]
15. The role of cytoreductive surgery in nongenital cancers metastatic to the ovaries.
Ayhan A; Guvenal T; Salman MC; Ozyuncu O; Sakinci M; Basaran M
Gynecol Oncol; 2005 Aug; 98(2):235-41. PubMed ID: 15982725
[TBL] [Abstract][Full Text] [Related]
16. Laparoscopic bilateral salpingo-oophorectomy in breast cancer patients after transverse rectus abdominus myocutaneous flap reconstructive surgery.
Awtrey CS; Abu-Rustum NR; Disa JJ; Ivy JJ; Kauff ND; Hummer AJ; Barakat RR
Gynecol Oncol; 2005 Dec; 99(3):720-5. PubMed ID: 16169063
[TBL] [Abstract][Full Text] [Related]
17. [Significance of prophylactic ovariectomy at the time of uterus extirpation for prevention of an ovarian carcinoma].
Petru E; Woltsche M; Lahousen M; Pickel H; Heydarfadai M; Stettner H
Wien Med Wochenschr; 1991; 141(8):153-6. PubMed ID: 1891916
[TBL] [Abstract][Full Text] [Related]
18. Ovarian pathology in risk-reducing salpingo-oophorectomies from women with BRCA mutations, emphasizing the differential diagnosis of occult primary and metastatic carcinoma.
Rabban JT; Barnes M; Chen LM; Powell CB; Crawford B; Zaloudek CJ
Am J Surg Pathol; 2009 Aug; 33(8):1125-36. PubMed ID: 19440148
[TBL] [Abstract][Full Text] [Related]
19. Malignancies following bilateral salpingo-oophorectomy (BSO).
Gotlieb WH; Barchana M; Ben-Baruch G; Friedman E
Eur J Surg Oncol; 2006 Dec; 32(10):1231-4. PubMed ID: 16626923
[TBL] [Abstract][Full Text] [Related]
20. Climacteric symptoms in women undergoing risk-reducing bilateral salpingo-oophorectomy.
Benshushan A; Rojansky N; Chaviv M; Arbel-Alon S; Benmeir A; Imbar T; Brzezinski A
Climacteric; 2009 Oct; 12(5):404-9. PubMed ID: 19479488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
